fluconazol medochemie 50 mg
medochemie ltd. - cipru - fluconazolum - caps. - 50mg - antimicotice de uz sistemic derivati de triazol
fluconazol medochemie 150 mg
medochemie ltd. - cipru - fluconazolum - caps. - 150mg - antimicotice de uz sistemic derivati de triazol
docetaxel dr reddy's 20 mg/1 ml
dr. reddy's laboratories romania s.r.l. - docetaxelum - conc. pt. sol. perf. - 20mg/1ml - alcaloizi din plante si alte produse naturale taxani
docetaxel dr reddy's 80 mg/4 ml
dr. reddy's laboratories romania s.r.l. - docetaxelum - conc. pt. sol. perf. - 80mg/4ml - alcaloizi din plante si alte produse naturale taxani
docetaxel dr. reddys 160mg/8 ml"
dr. reddy's laboratories romania s.r.l. - docetaxelum - conc. pt. sol. perf. - 160mg/8ml - alcaloizi din plante si alte produse naturale taxani
lorviqua
pfizer europe ma eeig - lorlatinib - carcinom, pulmonar non-celulă mică - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.
capecitabina dr. reddy's 500 mg
betapharm arzneimittel gmbh - germania - capecitabinum - compr. film. - 500mg - antimetaboliti analogi ai bazelor pirimidinice
sunitinib dr. reddy's 12,5 mg
synthon hispania, s.l. - spania - sunitinibum - caps. - 12,5mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
sunitinib dr. reddy's 25 mg
synthon hispania, s.l. - spania - sunitinibum - caps. - 25mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
sunitinib dr. reddy's 50 mg
synthon hispania, s.l. - spania - sunitinibum - caps. - 50mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza